Q32 Bio, Inc. (QTTB)
16.34
+0.37
(+2.32%)
USD |
NASDAQ |
Aug 24, 16:00
16.34
0.00 (0.00%)
After-Hours: 20:00
Q32 Bio Shareholders Equity (Quarterly) : 105.90M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 105.90M |
| March 31, 2026 | 46.31M |
| December 31, 2025 | 42.01M |
| September 30, 2025 | -18.45M |
| June 30, 2025 | -12.24M |
| March 31, 2025 | -4.014M |
| December 31, 2024 | 5.675M |
| September 30, 2024 | 18.30M |
| June 30, 2024 | 33.51M |
| March 31, 2024 | 48.77M |
| December 31, 2023 | -71.48M |
| September 30, 2023 | 88.21M |
| June 30, 2023 | 119.38M |
| March 31, 2023 | 151.90M |
| December 31, 2022 | 177.98M |
| September 30, 2022 | 209.06M |
| June 30, 2022 | 240.29M |
| March 31, 2022 | 266.25M |
| Date | Value |
|---|---|
| December 31, 2021 | 169.65M |
| September 30, 2021 | 198.57M |
| June 30, 2021 | 224.58M |
| March 31, 2021 | 200.83M |
| December 31, 2020 | 196.00M |
| September 30, 2020 | 170.22M |
| June 30, 2020 | 194.70M |
| March 31, 2020 | 226.54M |
| December 31, 2019 | 258.51M |
| September 30, 2019 | 257.82M |
| June 30, 2019 | 284.74M |
| March 31, 2019 | 174.26M |
| December 31, 2018 | 196.36M |
| September 30, 2018 | 212.76M |
| June 30, 2018 | 226.80M |
| March 31, 2018 | 88.24M |
| December 31, 2017 | 98.31M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Rallybio Corp. | 94.50M |
| Beam Therapeutics, Inc. | 1.067B |
| C4 Therapeutics, Inc. | 247.26M |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 115.87M |
| Total Liabilities (Quarterly) | 9.962M |
| Debt to Equity Ratio | 0.05 |
| Current Ratio | 20.28 |
| Net Debt Paydown Yield | 0.89% |